BridgeBio Pharma, Inc. (BBIO): 8-K filed Jul 2, 2026

Form type

8-K

Filing date

Jul 2, 2026

Accession number

0001140361-26-027445

Filer

BridgeBio Pharma, Inc. (CIK 1743881)